SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-22-003077
Filing Date
2022-05-18
Accepted
2022-05-18 17:12:28
Documents
1
Period of Report
2022-05-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 27097
  Complete submission text file 0001179110-22-003077.txt   28398
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address
SEVERINO MICHAEL (Reporting) CIK: 0001609447 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35565 | Film No.: 22940141